Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... Criteria:  Diagnosis of acute myelogenous leukemia , chronic myelogenous leukemia, other myeloproliferative disorder, ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  2. Clone of Myelodysplastic Syndromes (MDS)

    ... others are more severe, and carry a high risk of becoming acute myelogenous leukemia (AML). The subtype you have, and the severity of your ...

    Page last updated 04/05/2016 - 3:56pm.

  3. RIC Transplant Using Haplo Donors

    ... study is to estimate the incidence of graft rejection and acute GVHD. A secondary objective will be to estimate the incidence of the ... One of the following high-risk malignancies: Chronic Myelogenous Leukemia: Chronic myelogenous leukemia in chronic phase, resistant ...

    Clinical Trial last updated 04/29/2016 - 10:52am.

  4. Intra-Osseous Co-Transplant of UCB and hMSC

    ... must have one of the following malignancies: Acute myelogenous leukemia (AML): high-risk AML including: Antecedent ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  5. MDS: Diagnosis

    ... about the CBC test. The Risk of Getting AML ( Acute Myelogenous Leukemia ) AML is a cancer of the white blood cells. It is ...

    Page last updated 01/20/2015 - 4:42pm.

  6. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... remission or with stable minimal residual disease Acute myelogenous leukemia (AML) in 1st or subsequent remission or in relapse ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  7. Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

    ... range from zero to 30% but are typically short lived. Acute Lymphoblastic Leukemia (ALL) in first complete remission (CR1) that is NOT considered favorable-risk. Acute Myelogenous Leukemia (AML) in first complete remission (CR1) that is NOT ...

    Clinical Trial last updated 06/06/2016 - 10:54am.

  8. An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)

    ... chronic myelomonocytic leukemia and low-blast acute myelogenous leukemia . ...

    Clinical Trial last updated 04/28/2016 - 1:58pm.

  9. StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

    ... by molecular typing). Eligible Diseases Acute myelogenous leukemia (AML) at the following stages: Intermediate to ...

    Clinical Trial last updated 06/03/2016 - 2:37pm.

  10. Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-3032b in Hematological Malignancies

    ... (RP2D) in subjects with refractory or relapsed Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic ...

    Clinical Trial last updated 04/29/2016 - 1:50pm.